Open Access iconOpen Access

VIEWPOINT

crossmark

AAV-based gene therapy approaches for genetic forms of tauopathies and related neurogenetic disorders

MOHAMED AGHYAD AL KABBANI1,2, GILBERT WUNDERLICH3,4, CHRISTOPH KöHLER5, HANS ZEMPEL1,2,*

1 Faculty of Medicine and University Hospital Cologne, Institute of Human Genetics, University of Cologne, Cologne, 50931, Germany
2 Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, 50931, Germany
3 Faculty of Medicine and University Hospital Cologne, Department of Neurology, University of Cologne, Cologne, 50937, Germany
4 Faculty of Medicine and University Hospital Cologne, Center for Rare Diseases, University of Cologne, Cologne, 50937, Germany
5 Faculty of Medicine and University Hospital Cologne, Center Anatomy, Department of Molecular and Translational Neuroscience, University of Cologne, Cologne, 50931, Germany

* Corresponding Author:HANS ZEMPEL. Email: email

TSP_BIOCELL_18144.pdf

  • 1725

    View

  • 771

    Download

  • 0

    Like

Share Link